The New Zealand experience.
D001241:Aspirin / Q000009:adverse effects*; D004338:Drug Combinations; D004357:Drug Synergism; D006801:Humans; D007681:Kidney Papillary Necrosis / Q000139:chemically induced* / Q000453:epidemiology; D009520:New Zealand; D010615:Phenacetin / Q000009:adverse effects*; D010653:Phenylbutazone / Q000009:adverse effects; D019966:Substance-Related Disorders
D004338:Drug Combinations; D010615:Phenacetin; D010653:Phenylbutazone; D001241:Aspirin